MaxCyte Signs Platform License Agreement with Adicet Bio
August 04, 2025 08:05 ET | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation®…
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International Conference
July 24, 2025 07:00 ET | Source: INmune Bio, Inc. Boca Raton,…
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:00 ET | Source: Vor Biopharma CAMBRIDGE, Mass., July…
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass.,…
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET | Source: Belite Bio, Inc - 500…
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Vanqua Bio to Present at Upcoming Scientific Conferences
CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical…
